Bevan DR - Search Results

1

Natural product-based amyloid inhibitors.

Velander P, Wu L, Henderson F, Zhang S, Bevan DR, Xu B. Velander P, et al. Among authors: bevan dr. Biochem Pharmacol. 2017 Sep 1;139:40-55. doi: 10.1016/j.bcp.2017.04.004. Epub 2017 Apr 6. Biochem Pharmacol. 2017. PMID: 28390938 Free PMC article. Review.

2

Rosmarinic Acid Potently Detoxifies Amylin Amyloid and Ameliorates Diabetic Pathology in a Transgenic Rat Model of Type 2 Diabetes.

Wu L, Velander P, Brown AM, Wang Y, Liu D, Bevan DR, Zhang S, Xu B. Wu L, et al. Among authors: bevan dr. ACS Pharmacol Transl Sci. 2021 Jul 21;4(4):1322-1337. doi: 10.1021/acsptsci.1c00028. eCollection 2021 Aug 13. ACS Pharmacol Transl Sci. 2021. PMID: 34423269 Free PMC article.

3

The role of molecular simulations in the development of inhibitors of amyloid β-peptide aggregation for the treatment of Alzheimer's disease.

Lemkul JA, Bevan DR. Lemkul JA, et al. Among authors: bevan dr. ACS Chem Neurosci. 2012 Nov 21;3(11):845-56. doi: 10.1021/cn300091a. Epub 2012 Aug 27. ACS Chem Neurosci. 2012. PMID: 23173066 Free PMC article. Review.

4

Morin inhibits the early stages of amyloid β-peptide aggregation by altering tertiary and quaternary interactions to produce "off-pathway" structures.

Lemkul JA, Bevan DR. Lemkul JA, et al. Among authors: bevan dr. Biochemistry. 2012 Jul 31;51(30):5990-6009. doi: 10.1021/bi300113x. Epub 2012 Jul 16. Biochemistry. 2012. PMID: 22762350

5

Molecular docking of inhibitors into monoamine oxidase B.

Harkcom WT, Bevan DR. Harkcom WT, et al. Among authors: bevan dr. Biochem Biophys Res Commun. 2007 Aug 24;360(2):401-6. doi: 10.1016/j.bbrc.2007.06.055. Epub 2007 Jun 18. Biochem Biophys Res Commun. 2007. PMID: 17597580

6

Molecular Dynamics Simulations of Amyloid β-Peptide (1-42): Tetramer Formation and Membrane Interactions.

Brown AM, Bevan DR. Brown AM, et al. Among authors: bevan dr. Biophys J. 2016 Sep 6;111(5):937-49. doi: 10.1016/j.bpj.2016.08.001. Biophys J. 2016. PMID: 27602722 Free PMC article.

7

Simulations of cross-amyloid aggregation of amyloid-β and islet amyloid polypeptide fragments.

Kawecki GE, King KM, Cramer NA, Bevan DR, Brown AM. Kawecki GE, et al. Among authors: bevan dr. Biophys J. 2022 Jun 7;121(11):2002-2013. doi: 10.1016/j.bpj.2022.05.007. Epub 2022 May 10. Biophys J. 2022. PMID: 35538665 Free PMC article.

8

Probing the substitution pattern of indole-based scaffold reveals potent and selective sphingosine kinase 2 inhibitors.

Congdon M, Fritzemeier RG, Kharel Y, Brown AM, Serbulea V, Bevan DR, Lynch KR, Santos WL. Congdon M, et al. Among authors: bevan dr. Eur J Med Chem. 2021 Feb 15;212:113121. doi: 10.1016/j.ejmech.2020.113121. Epub 2020 Dec 29. Eur J Med Chem. 2021. PMID: 33445156 Free PMC article.

9

Aggregation of Alzheimer's amyloid β-peptide in biological membranes: a molecular dynamics study.

Lemkul JA, Bevan DR. Lemkul JA, et al. Among authors: bevan dr. Biochemistry. 2013 Jul 23;52(29):4971-80. doi: 10.1021/bi400562x. Epub 2013 Jul 15. Biochemistry. 2013. PMID: 23855340

10

Assessing the stability of Alzheimer's amyloid protofibrils using molecular dynamics.

Lemkul JA, Bevan DR. Lemkul JA, et al. Among authors: bevan dr. J Phys Chem B. 2010 Feb 4;114(4):1652-60. doi: 10.1021/jp9110794. J Phys Chem B. 2010. PMID: 20055378

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

273 results

Search Page